Parameter | Placebo (A) (n = 18) | Phyllanthus emblica 250 mg (B) (n = 20) | Phyllanthus emblica 500 mg (C) (n = 21) | ||||||
---|---|---|---|---|---|---|---|---|---|
 | Baseline | 12 weeks | Mean % change | Baseline | 12 weeks | Mean % change | Baseline | 12 weeks 12 weeks | Mean % change |
TC (mg/dl) | 179.16 ± 18.2 | 184.16 ± 20.8 | 2.78% | 178.9 ± 21 | 165.7 ± 17.3*§ | −7.17% †| 183.48 ± 23.8 | 162.5 ± 18.9 *†| −11.11% †‡ |
HDL-C (mg/dl) | 33.28 ± 2.74 | 33.29 ± 2.79 | 0.57% | 32.75 ± 2.34 | 35.10 ± 4.24||¶ | 7.33% ¶ | 31.57 ± 2.44 | 38.48 ± 3.28 *†| 22.16%†∞ |
LDL-C (mg/dl) | 136.7 ± 16.02 | 141.6 ± 14.79 | 3.83% | 133.2 ± 18.31 | 118.1 ± 17.9*†| −11.39%†| 134.86 ± 12.24 | 105.52 ± 14.17*†| −21.80%†∞ |
TG (mg/dl) | 184.3 ± 19.82 | 184.7 ± 21.62 | 0.18% | 184.4 ± 28.05 | 165.9 ± 23.43*¶ | −9.81%†| 198.19 ± 31.84 | 157.24 ± 18.12*†| −19.22% †£ |